Responses
Obesity studies
Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study
Compose a Response to This Article
Other responses
No responses have been published for this article.